The association of COVID-19 with diffuse large B-cell lymphoma: a Mendelian randomization study.
暂无分享,去创建一个
[1] Shuqun Zhang,et al. Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study , 2023, Journal of medical virology.
[2] E. Birney. Mendelian Randomization. , 2021, Cold Spring Harbor perspectives in medicine.
[3] Tianxin Lin,et al. Kidney damage causally affects the brain cortical structure: A Mendelian randomization study , 2021, EBioMedicine.
[4] Walter Gottlieb Land,et al. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia , 2021, Genes & Immunity.
[5] Jiang Ren,et al. The intersection of COVID-19 and cancer: signaling pathways and treatment implications , 2021, Molecular cancer.
[6] G. Saini,et al. Cancer as a prospective sequela of long COVID‐19 , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.
[7] Guohui Fan,et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.
[8] E. Diamandis,et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences , 2020, Critical reviews in clinical laboratory sciences.
[9] J. Tardif,et al. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine , 2020, Annals of the Rheumatic Diseases.
[10] C. Nwagwu,et al. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology , 2020, International Immunopharmacology.
[11] P. Filipe,et al. Persistent SARS-CoV-2 infection and the risk for cancer , 2020, Medical Hypotheses.
[12] The COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic , 2020, European Journal of Human Genetics.
[13] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[15] Jack Bowden,et al. Meta‐analysis and Mendelian randomization: A review , 2019, Research synthesis methods.
[16] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[17] Cristian Pattaro,et al. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. , 2016, Journal of the American Society of Nephrology : JASN.
[18] G. Davey Smith,et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies1 , 2016, The American journal of clinical nutrition.
[19] Dylan S. Small,et al. A review of instrumental variable estimators for Mendelian randomization , 2015, Statistical methods in medical research.
[20] K. Khalili,et al. Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms , 2014, Clinical Microbiology Reviews.
[21] A. Gozdzicka-Jozefiak,et al. Epigenetic mechanisms in virus-induced tumorigenesis , 2011, Clinical Epigenetics.
[22] K. Kalland,et al. Tumour virology – history, status and future challenges , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[23] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[24] M. Epstein,et al. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.
[25] T. Hagemann,et al. Cancer-Related Inflammation , 2012, Journal of Clinical Immunology.